Volume | 311,117 |
|
|||||
News | - | ||||||
Day High | 22.47 | Low High |
|||||
Day Low | 21.8864 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Cassava Sciences Inc | SAVA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
22.35 | 21.8864 | 22.47 | 22.27 | 22.095 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
5,498 | 311,117 | $ 22.19 | $ 6,904,111 | - | 12.3202 - 32.10 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:37:37 | 2 | $ 22.28 | USD |
Cassava Sciences (SAVA) Options Flow Summary
Cassava Sciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.3M | 43.23M | - | 0 | -97.22M | -2.25 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Cassava Sciences News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SAVA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 21.50 | 24.12 | 21.36 | 22.83 | 945,682 | 0.77 | 3.58% |
1 Month | 20.65 | 24.12 | 19.93 | 21.99 | 873,408 | 1.62 | 7.85% |
3 Months | 22.10 | 26.6757 | 18.18 | 21.68 | 872,736 | 0.17 | 0.77% |
6 Months | 22.50 | 32.10 | 18.18 | 23.70 | 916,895 | -0.23 | -1.02% |
1 Year | 24.29 | 32.10 | 12.3202 | 21.57 | 990,595 | -2.02 | -8.32% |
3 Years | 50.94 | 146.16 | 12.3202 | 49.43 | 2,363,981 | -28.67 | -56.28% |
5 Years | 1.05 | 146.16 | 1.02 | 34.33 | 2,799,331 | 21.22 | 2,020.95% |
Cassava Sciences Description
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. |